Thus, urinary L-FABP levels on admission are potential and independent predictors of long-term adverse outcomes, and when used in combination with creatinine-defined AKI, they might improve the long-term risk stratification of patients hospitalized at medical CICUs. Here, FABP1 is linked to acute kidney injury.